ArticleCancers2022

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.

Christophe Bonnet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.